Vote for your favorite mineral in #MinCup25! - Zunyite vs. Molybdenite
It's the visually-unmistakable #zunyite vs the physically funky #molybdenite.
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

Duncan, R., Song, Bob, Koulen, Peter (2018) Presenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development. International Journal of Molecular Sciences, 19. 1621pp. doi:10.3390/ijms19061621

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitlePresenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development
JournalInternational Journal of Molecular Sciences
AuthorsDuncan, R.Author
Song, BobAuthor
Koulen, PeterAuthor
Year2018 (May 31)Volume19
PublisherMDPI AG
DOIdoi:10.3390/ijms19061621Search in ResearchGate
Generate Citation Formats
Mindat Ref. ID10069710Long-form Identifiermindat:1:5:10069710:4
GUID0
Full ReferenceDuncan, R., Song, Bob, Koulen, Peter (2018) Presenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development. International Journal of Molecular Sciences, 19. 1621pp. doi:10.3390/ijms19061621
Plain TextDuncan, R., Song, Bob, Koulen, Peter (2018) Presenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development. International Journal of Molecular Sciences, 19. 1621pp. doi:10.3390/ijms19061621
In(n.d.) International Journal of Molecular Sciences Vol. 19. MDPI AG

See Also

These are possibly similar items as determined by title/reference text matching only.

Rohowetz, Landon, Kraus, Jacob, Koulen, Peter (2018) Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina. International Journal of Molecular Sciences, 19. 3362pp. doi:10.3390/ijms19113362
Puranik, Nidhi, Song, Minseok (2024) Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease. International Journal of Molecular Sciences, 25 (18). doi:10.3390/ijms25189936
Dong, Yuan, Li, Xiaoheng, Cheng, Jinbo, Hou, Lin (2019) Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?. International Journal of Molecular Sciences, 20. 558pp. doi:10.3390/ijms20030558
Xing, Haonan; Yue, Song; Qin, Runtian; Du, Xiaoxue; Wu, Yili; Zhangsun, Dongting; Luo, Sulan (2025) Recent Advances in Drug Development for Alzheimer’s Disease: A Comprehensive Review. International Journal of Molecular Sciences, 26 (8). doi:10.3390/ijms26083905
Penke, Botond, Szűcs, Mária, Bogár, Ferenc (2023) New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, 24 (6) 5383 doi:10.3390/ijms24065383
Quick, Quincy (2018) Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets. International Journal of Molecular Sciences, 19. 368pp. doi:10.3390/ijms19020368
Kim, Sung-Kun (2023) Enzymes as Targets for Drug Development II. International Journal of Molecular Sciences, 24 (4) 3258 doi:10.3390/ijms24043258
Perez, Dianne M. (2023) α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease. International Journal of Molecular Sciences, 24 (4) 4188 doi:10.3390/ijms24044188
Teijido, Oscar, Cacabelos, Ramón (2018) Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases. International Journal of Molecular Sciences, 19. 3199pp. doi:10.3390/ijms19103199
Er, Teagan Seng-Mei; Martinac, Boris; Hool, Livia C. (2025) Novel Drug Targets in Diastolic Heart Disease. International Journal of Molecular Sciences, 26 (16). doi:10.3390/ijms26168055
Choi, Tae-Woo, Cho, Jeong, Ahnn, Joohong, Song, Hyun-Ok (2018) Novel Findings of Anti-Filarial Drug Target and Structure-Based Virtual Screening for Drug Discovery. International Journal of Molecular Sciences, 19. 3579pp. doi:10.3390/ijms19113579
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 12, 2025 08:29:52
Go to top of page